摘要
As part of a continuing study, we designed and synthesized four series of 1-phenylimidazole-4-carboxylic acid derivatives as xanthine oxidoreductase (XOR) inhibitors, evaluated their in vitro inhibitory potencies against XOR and hypouricemic effects in mice, and determined their structure-activity relationships (SARs). Most of the compounds exhibited in vitro XOR inhibition at the nanomolar level. In comparison to febuxostat (half-maximal inhibitory concentration [IC50] value of 7.0 nM), compounds le and Na exhibited the most promising XOR inhibitory effects with IC50 values of 8.0 and 7.2 nM, respectively. In the potassium oxonate/hypoxanthine-induced acute and long-term hyperuricemia mouse models, compounds Ie and Na displayed significant hypouricemic potencies (P < 0.05), that were slightly weaker than and similar to febuxostat, respectively. More interestingly, both compounds showed a capacity to improve kidney damage by decreasing creatinine and urea nitrogen levels compared to the long-term hyperuricemia mouse group (P < 0.05), while febuxostat showed no significant effect.
学科与关键词
- Design, synthesis, and evaluation of tricyclic compounds containing phenyl-tetrazole as XOR inhibitorsPeng, Wen; Liu, Fuyao; Zhang, Lei; Zhang, Liying*; Li, Jing*European Journal of Medicinal Chemistry, 2023, 246: 114947.
- Design, synthesis, and evaluation of the in vitro activity of novel dual inhibitors of XOR and URAT1 containing a benzoic acid groupZhu, Xin Ying; Chen, Hong Ming; Zhang, Lei; Qin, Yu Xiang; Li, Jing*Chemical Biology and Drug Design, 2023, 102(6): 1553-1567.
- Anti-hyperuricemia activity and toxicity prediction of a novel xanthine oxidoreductase inhibitorZhou, Liping; Wei, Baxiong; Wu, Lvying; Li, Jing; Zhu, Bin*; Zhang, Lei*Biomedical Chromatography, 2020, 34(2): e4727.被引 2
